Two Sigma Securities, LLC Catalyst Biosciences, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.33 - $0.65 $6,612 - $13,025
20,039 New
20,039 $9,000
Q1 2023

May 15, 2023
BUY
$0.19 - $0.64 $2,084 - $7,022
10,972 Added 27.58%
50,750 $10,000
Q4 2022

Feb 14, 2023
BUY
$0.49 - $0.57 $12,822 - $14,916
26,169 Added 192.29%
39,778 $21,000
Q3 2022

Nov 14, 2022
BUY
$0.49 - $1.95 $6,668 - $26,537
13,609 New
13,609 $7,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email